WES Panel Event: From Lab to Product - Meet Cambridge Health Tech Founders

A hand holds a clear lightbulb against a serene backdrop of blue and pink sky.
Date 24/11/2025 at 17.30 - 24/11/2025 at 19.30 Where Gatsby Room (Chancellor's Centre) & Zoom

Join us for a conversation with founders who have successfully transformed cutting-edge biomedical research into real-world health technologies.

A hand holds a clear lightbulb against a serene backdrop of blue and pink sky.

Overview

This panel discussion will explore how scientific discoveries in the lab evolve into scalable startups, all the way from initial prototype to patient impact. Our speakers will share lessons on navigating the translational journey: building interdisciplinary teams, protecting intellectual property, raising investment, and meeting the unique regulatory and clinical challenges of HealthTech. Whether you’re a researcher, clinician, or aspiring entrepreneur, this session offers practical insight into how innovation in medicine moves from the bench to the bedside and what it takes to turn research into products that improve lives.

 

Featured Speakers

Clarity Sensors

Clarity Sensors is developing high-performance perovskite semiconductor X-ray detectors for medical imaging, with the goal of producing clearer imaging at lower radiation doses. Their work sits at the intersection of materials science, imaging hardware, and healthcare needs, representing a fantastic example of bridging lab innovation to a clinical product.

Peter Neurotech

Peter is a wearable device for Parkinson’s patients that combats freezing of gait, a debilitating symptom. It uses bone-conduction auditory cues to re-engage walking. This start-up was founded by Wolfson MPhil student (2024), Jonathan Fisher, and won the global health prize at last year’s Wolfson Entrepreneurship competition. Jon has leveraged the available accelerators and other resources in Cambridge to land an innovation fellowship with Cambridge NeuroWorks to commercialise his research.

Dr. Farid Khan is an accomplished biotech entrepreneur and respected scientist with deep knowledge of the life sciences industry. He obtained his Ph.D. in recombinant protein engineering from the University of Cambridge and previously worked in drug discovery at GlaxoSmithKline. A visionary leader, he has founded multiple companies to develop technologies and therapies for diseases affecting people worldwide. His extensive experience in biotechnology and commercialization makes him highly derisible for positions as a NED or chairperson.

Details

This is a hybrid event which is open to all members of the University of Cambridge and is free to attend. Please book your place using the form below.

Online attendees will be emailed a link to access the event.

 

 

Access

This event will take place in the Gatsby Room on the first floor of the Chancellor's Centre. It has step-free access with a lift and there is an accessible toilet located each floor of the building.

 

Contact

If you have any questions, please contact our events team - events@wolfson.cam.ac.uk